Product Introduction
Name:Ara-290
Product Benefits:Improve diabetes-related complications
CAS:1208243-50-8
Capacity:10mg/vial
Product Form:White or off-white powder(Peptides)
Shelf Life:2-3Years(The product packaging date shall prevail)
What is the peptide Ara-290?
**Ara-290** (also known as **Amino Acid 290**) is a synthetic small peptide molecule that is mainly used to treat symptoms such as pain and inflammation caused by nerve damage. It is obtained from *Aminothiazole-290* (Ara-290 for short) and belongs to a new class of immunomodulatory peptide compounds.
The mechanism of action of Ara-290 is different from that of traditional analgesics. It is a peptide drug with neuroprotective and anti-inflammatory effects that can interact with the immune system and nervous system through specific receptors to regulate pain perception and reduce inflammatory responses caused by nerve damage.
### **Physical and chemical properties**
- **Molecular weight**: The molecular weight of Ara-290 is approximately **290 Da**.
- **Molecular structure**: It is a short-chain peptide composed of multiple amino acids with a relatively simple structure. The peptide molecule binds to certain receptors on the surface of neurons to exert its effects.
- **Solubility**: Ara-290 has a high solubility in water and is suitable for injection or intravenous administration.
- **Stability**: As a peptide molecule, Ara-290 is relatively stable at room temperature, but usually needs to be stored under refrigerated conditions to ensure its long-term stability.
### **Mechanism of Action**
The main mechanism of action of Ara-290 is to regulate the response of the immune and nervous systems by binding to specific receptors. It mainly reduces the burden on the nervous and immune systems by binding to **C-X-C Chemokine Receptor 1 (CXCR1)** and **CXCR2** receptors, improving symptoms related to nerve damage, such as chronic pain, neuroinflammation, etc.
#### **Anti-inflammatory Effect**:
Ara-290 can reduce excessive inflammatory responses caused by nerve damage by regulating immune responses. This mechanism of action makes it potential in the treatment of pain and chronic inflammation caused by nerve damage or other pathological stimuli.
#### **Neuroprotective Effect**:
It can promote nerve repair and regeneration, and alleviate symptoms caused by nerve damage (such as diabetic neuropathy), such as sensory loss and muscle weakness.
### **Dosage and Use**
The dose of Ara-290 is usually adjusted according to the individual's condition and specific treatment needs. Generally speaking, when used clinically, it is usually provided in an injectable dosage form and is administered by intravenous or subcutaneous injection.
#### **Common Doses**:
- **Initial Dose**: For the first treatment, the dose may be **10-20 mg**, usually given once within 24 hours, or multiple doses as scheduled according to the treatment plan.
- **Maintenance Dose**: For continued treatment, the dose may be gradually reduced to avoid overstimulating the immune system.
### **Half-Life**
Ara-290 has a short half-life. According to current research data, its half-life in the body is approximately **2-3 hours**, which means that its duration of efficacy is relatively short and requires frequent dosing to maintain effective concentrations. During treatment, it is usually necessary to administer once a day or every few days.
### **Pharmacokinetics**
The pharmacokinetic properties of Ara-290 indicate that it is rapidly distributed and metabolized in the body, mainly through the liver and kidneys. Due to its small molecular structure, Ara-290 can enter the blood circulation relatively quickly and take effect in a short period of time.
### **Course and cycle**
- **Acute treatment**: For acute nerve damage or related diseases, short-term treatment is usually used, which may last for a few days or a week.
- **Chronic conditions**: For chronic neuropathy (such as diabetic neuropathy or chronic pain), the course of treatment may be longer, and the treatment cycle can reach several weeks or months. The specific course of treatment is adjusted by the doctor according to the patient's condition and response.
### **Clinical application**
Ara-290 is mainly used to treat diseases related to nerve damage, especially in the treatment of chronic neuroinflammation, pain caused by nerve damage, diabetic neuropathy, etc. It can reduce pain and dysfunction caused by nerve damage, and promote nerve repair and regeneration to a certain extent.
### **Side effects and risks**
Current clinical studies have shown that Ara-290 has relatively few side effects, but it may also trigger some immune system or allergic reactions, especially when used for a long time or in large doses. Common side effects may include:
- **Injection site reactions**: such as redness, swelling, pain, nodules, etc.
- **Mild allergic reactions**: such as rash, fever, etc.
- **Immunomodulatory effects**: may cause activation or imbalance of the immune system.
### **Summary**
Ara-290 is a new type of peptide immunomodulator that mainly regulates nerve and immune responses by binding to CXCR1 and CXCR2 receptors, thereby reducing pain and inflammation caused by nerve damage. It is mainly used clinically to treat chronic nerve damage, neuroinflammation and pain-related diseases. It has a short half-life, and the dosage and course of treatment need to be adjusted according to the specific situation of the patient. Although it has fewer side effects, it still needs to be used under the guidance of a doctor.

What is the dosage and administration of the peptide Ara-290?
**Ara-290** (also known as peptide Ara-290) is an experimental drug that is mainly used to treat some chronic inflammatory diseases and pain and damage associated with neurodegenerative diseases. Its mechanism of action is related to its specific binding and regulation of certain receptors. The following is a detailed introduction:
### 1. **Applicable population**
Ara-290 is mainly aimed at the following populations:
- **Patients with chronic inflammatory diseases**: especially those associated with diabetes, neuropathic pain, and chronic immune system diseases (such as rheumatoid arthritis).
- **Patients with neurodegenerative diseases**: patients with diseases such as multiple sclerosis and Alzheimer's disease, mainly because these diseases are often accompanied by chronic inflammatory responses of nerves.
- **Patients with nerve damage caused by diabetes**: for example, diabetic neuropathy (DPN) suffered by diabetic patients.
The role of Ara-290 is not limited to relieving inflammation, but may also help reduce symptoms associated with nerve damage, such as pain and sensory impairment.
### 2. **Working Principle**
Ara-290 is a synthetic small peptide, usually a specific peptide chain derivative bound by **C1q receptor (C1qR)**, which binds to specific immune receptors and neural receptors to exert its effects. Its working principle can be briefly summarized as follows:
- **Anti-inflammatory effect**: Ara-290 acts on the body's immune system, especially by activating receptors related to immune response, inhibiting excessive immune activation, thereby reducing chronic inflammatory response. This makes it effective in treating inflammatory symptoms caused by abnormal immune system.
- **Neuroprotective effect**: Ara-290 can relieve pain and other discomfort caused by nerve damage by regulating the activity of neurotransmitters and receptors in the nervous system.
- **Immunomodulatory effect**: In addition to its anti-inflammatory effect, Ara-290 can also regulate the activity of some immune cells and reduce the overreaction of the immune system, so it has great potential for application in a variety of chronic diseases (such as autoimmune diseases).
### 3. **Dosage**
The administration method and dosage of Ara-290 are usually determined by the doctor based on the patient's specific condition and treatment response. The following are some common dosage references:
- **Dosage**: Ara-290 is usually given to patients in the form of **injection formulation**, and the common administration route is **subcutaneous injection** or **intravenous injection**. The specific administration route depends on the drug formulation and treatment plan.
- **Dosage**: In clinical trials, the common dosage range is once a day, and each dose is usually **1-2 mg**. The dose may be adjusted according to the patient's response and tolerance. For patients with chronic inflammation or nerve damage, the dose may be gradually increased.
- **Treatment cycle**: Since Ara-290 is an experimental drug, the treatment cycle will vary depending on clinical research and changes in the patient's condition. Some patients may require long-term treatment to ensure that inflammation is controlled and nerve damage is repaired.
**Precautions**:
- Since Ara-290 is an experimental drug, it needs to be used under the guidance of a professional doctor before use, especially in the clinical trial stage.
- Side effects of the drug may include mild allergic reactions, pain or swelling at the local injection site, etc., so the patient's tolerance needs to be closely observed.
- If the patient is taking other drugs, especially immunomodulatory drugs, special attention should be paid to drug interactions when using Ara-290.
### 4. **Clinical prospects**
As a new type of peptide drug, Ara-290 is still in the clinical trial stage, but it has shown potential in multiple areas, including:
- **Diabetic neuropathy**: It has shown significant efficacy in patients with diabetic neuropathy in some clinical trials, helping to relieve neuropathic pain.
- **Chronic inflammatory diseases**: It has therapeutic potential for rheumatoid arthritis and other diseases caused by abnormal immune system.
- **Neurodegenerative diseases**: In early studies of neurodegenerative diseases such as Alzheimer's disease, Ara-290 is also considered a potential therapeutic tool.
### Summary
As a peptide drug, Ara-290 mainly relieves symptoms caused by abnormal immune system or nerve damage through anti-inflammatory and neuroprotective effects. It is suitable for patients with a variety of chronic diseases, especially those related to nervous system damage and immune system disorders. Although it is still in the clinical research stage, preliminary results show that it may have significant value in improving patients' quality of life.

Related Benefits of Peptide Ara-290
**Ara-290** (full name: **Argophosphodiester-290**) is a peptide molecule with anti-inflammatory and neuroprotective effects, belonging to the class of small molecule peptide drugs. It was originally developed by Argos Therapeutics, and has shown potential in multiple clinical studies, especially in the treatment of chronic diseases, neurological diseases, and inflammatory responses. The following is a detailed introduction to the many benefits of Ara-290:
### 1. **Anti-inflammatory effect**
Ara-290 can inhibit inflammatory responses by activating **IL-6 receptor** (interleukin 6 receptor). IL-6 is an important cytokine in the human body that usually promotes inflammatory responses in immune responses. In many chronic inflammatory diseases, overexpression of IL-6 is closely associated with the aggravation of the disease. Ara-290 reduces inflammatory responses by regulating the IL-6 signaling pathway, thereby helping to alleviate symptoms of diseases associated with inflammation.
#### Main Mechanism:
- Through the activation of IL-6 receptors, Ara-290 regulates the activity of T cells and macrophages in the immune system, reducing chronic inflammation caused by excessive activation of the immune system.
- It can reduce the release of cytokines, especially those that promote inflammation and immune responses.
### 2. **Neuroprotective Effect**
Ara-290 has significant **neuroprotective** effects, especially in the treatment of nerve damage caused by diseases such as **diabetic neuropathy**.
#### Mechanism of Action:
- Ara-290 can activate the **PI3K/Akt pathway** in the nervous system, thereby promoting the survival and regeneration of nerve cells.
- It helps repair nerve damage caused by the disease and reduces neuroinflammation, thereby relieving pain and other symptoms related to nerve damage.
### 3. **Improving Diabetes-Related Complications**
Patients with diabetes often face problems such as diabetic neuropathy, kidney damage, and retinopathy. Ara-290 has shown certain therapeutic potential in these areas.
#### Research results:
- In the treatment of diabetic neuropathy, Ara-290 relieves patients' symptoms such as **hyperalgesia**, **numbness** and **muscle weakness** by promoting **nerve repair**.
- For diabetic patients with kidney damage, Ara-290 has also been found to improve renal function and slow the progression of kidney disease by reducing renal inflammation and improving small blood vessel function.
### 4. **Improving symptoms of chronic diseases**
Chronic diseases, especially some diseases accompanied by nervous system damage and inflammation, such as **chronic pain**, **systemic lupus erythematosus**, **rheumatoid arthritis**, etc., Ara-290 may have potential benefits in the treatment of these diseases.
#### Main benefits:
- Relieve **inflammatory pain** caused by chronic diseases and improve patients' quality of life.
- In some diseases related to immune system dysfunction, Ara-290 helps control the activity of the disease by regulating immune response.
### 5. **Antioxidant effect**
Ara-290 can inhibit cell damage caused by oxidative stress and reduce cell aging and death caused by **free radicals**. Oxidative stress is usually the pathological basis of many chronic diseases, including **cardiovascular disease**, **cancer**, etc.
#### Research results:
- Inhibit the production of free radicals and reduce the risk of oxidative damage to cells.
- By reducing oxidative damage, it promotes the repair and regeneration of cells and tissues, thereby helping to delay the aging process and alleviate the progression of diseases.
### 6. **Improve immune system function**
Ara-290 can regulate the immune system, especially by **regulating T cells and macrophages**, it can enhance the stability of the immune system, thereby improving the symptoms of immune-related diseases.
#### Effects:
- In some diseases with immune system disorders, Ara-290 prevents tissue damage caused by excessive immune response by regulating immune response.
- In the process of regulating the immune system, Ara-290 can improve the immune system's ability to respond to external pathogens while avoiding excessive immune response.
### 7. **Potential adjuvant effect in cancer treatment**
Although the main application areas of Ara-290 are currently concentrated in inflammation, neuroprotection and immunomodulation, some studies have shown that it may also have certain adjuvant therapeutic effects on certain types of cancer, especially in reducing the side effects of cancer treatment.
#### Possible benefits:
- In cancer treatment, Ara-290 may help reduce the side effects of **nerve damage** and **pain** caused by radiotherapy and chemotherapy.
- Its anti-inflammatory and immunomodulatory effects may improve the overall immune function of cancer patients to a certain extent.
### 8. **Clinical research and prospects**
Ara-290 is currently undergoing multiple clinical studies, especially for the treatment of diabetic neuropathy, chronic inflammatory diseases, and neurodegenerative diseases. Preliminary studies have shown that Ara-290 has broad clinical application prospects, especially in the following areas:
- **Diabetic neuropathy**: It has shown the potential to relieve the symptoms of diabetic neuropathy in clinical trials.
- **Chronic inflammatory diseases**: including rheumatoid arthritis, systemic lupus erythematosus, etc. Ara-290 may become a potential treatment for these diseases.
### Conclusion
In general, as a peptide molecule with anti-inflammatory, neuroprotective and immunomodulatory effects, Ara-290 has been preliminarily verified in multiple medical fields, especially in neurological diseases, chronic inflammation, and diabetic complications. In the future, with the advancement of more clinical trials, Ara-290 is expected to become one of the important drugs for the treatment of these diseases.

Contact Details(WhatsApp Telegram ) And Payment Methods
WhatsApp/Telegram:+852 6749 2648
Gmail:lucasraws207@gmail.com
Skype:live:.cid.8f21dc7fc6621ba7

FAQ
Q: What is Ara-290?
A: Ara-290 is a synthetic peptide molecule derived from an endogenous small peptide. It mainly acts on a receptor system called "ligand-dependent activated receptor" (IL-6). In this way, Ara-290 can regulate immune responses, inhibit inflammation, and show potential in pain management caused by nerve damage or disease. Because its mechanism of action is different from traditional drug treatments, Ara-290 is considered to have important application prospects in the fields of neuropathic pain and immune-related diseases.
Q: What is the mechanism of action of Ara-290?
A: Ara-290 works by binding to specific receptors. It mainly activates a pathway called IL-6 receptor, which plays an important role in regulating the immune system, neuroinflammation, and neuroprotection. In particular, Ara-290 can promote nerve repair, reduce nerve damage caused by inflammation, and improve the function of the nervous system by slowing down excessive immune responses.
Hot Tags: peptides ara-290 10mg cas:1208243-50-8, China peptides ara-290 10mg cas:1208243-50-8 manufacturers, suppliers, factory, Sermorelin Build muscle and improve cardiovascular function, Ipamorelin CAS 170851 70 4, MGF Promote muscle repair and accelerate fat burning, PT141 CAS 32780 32 8, AOD9604 CAS 221231 10 3, AOD9604 No effect on blood sugar and growth

